Larvol Delta - Alterity-Therapeuticsannounced-the-successful-outcome-of-its-EndofPhase-2-EOP2-meeting-with-the-US-Food-and-Drug-Administration-FDA-achieving-alignment-on-the-key-elements-of-the-Company39s-registrational-Phase-3-program-for-ATH434-in-Multiple-System-Atrophy

ATH434 - Alterity Therap

https://www.manilatimes.net/2026/06/09/tmt-newswire/globenewswire/alterity-therapeutics-achieves-alignment-with-us-fda-on-pivotal-phase-3-program-for-ath434-in-multiple-system-atrophy/2361541

Jun 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next